Clal Biotechnology Industries – a leading Israeli life sciences investment company
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI). CBI supports life science ventures by identifying and empowering science-backed projects and proactively guiding them to fruition
The CBI portfolio is comprised of biotechnology and medical device companies developing breakthrough solutions for serious unmet medical needs, while offering substantial value and investment potential.
Elicio Therapeutics Anounces Positive Interim Data from the Phase 1 Study of an Investigational Therapeutic Cancer Imunotherapy, ELI-02, in Patients with High Relapse Risk Pancreatic and Colorectal Cancer athe ASCO Anual Meting Investigational Therapeutic Cancer Immunotherapy, ELI-002, in Patients with High Relapse Risk Pancreatic and Colorectal Cancer at the ASCO Annual Meeting